Showing results (741-750 of 813) with videos related to
Sort By:
Pageof 82
Pacing and Clinical Electrophysiology : PACE|October 11, 2016
Impact of Anatomically Guided Ganglionated Plexus Ablation on Electrical Firing from Isolated Pulmonary VeinsRu-Hong Jiang, Gen-Sheng Hu, Qiang Liu, et al.BMC Public Health|February 4, 2026
Evaluating peer navigation in promoting digital secondary distribution of HIV self-testing among men who have sex with men in China: study protocol for a two-arm randomized controlled trialHao Ren, Fengshi Jing, Xinyuan Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2012
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiativeApostolia-Maria Tsimberidou, Nancy G Iskander, David S Hong, et al.Biochemical Pharmacology|July 14, 2025
A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phaseChen-Chen Wang, Jilong Duan, Nian-Dong Mao, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonistsXiang-Yang Ye, Yi-Xin Li, Dennis Farrelly, et al.Journal of Zhejiang University. Science. B|November 10, 2017
Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablationJun Zhu, Rong-Jun Gao, Qiang Liu, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 2021
Resolvin Conjugates in Tissue Regeneration 1 Promote Alveolar Fluid Clearance by Activating Alveolar Epithelial Sodium Channels and Na, K-ATPase in Lipopolysaccharide-Induced Acute Lung InjuryQian Yang, Hao-Ran Xu, Shu-Yang Xiang, et al.Nature Communications|May 31, 2025
Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trialKe Liu, Bao-Dong Qin, Shi-Qi Chen, et al.Oncotarget|June 25, 2016
miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenaseXiao-Su Zhao, Yi-Nuo Wang, Meng Lv, et al.Journal of Medicinal Chemistry|July 10, 2008
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screeningLi-Gen Lin, Hua Xie, Hong-Lin Li, et al.Pageof 82